Add Company
Join Now

Diaccurate Revenue and Competitors

License our Company Data API

Paris, France

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Diaccurate's estimated annual revenue is currently $3.6M per year.(i)
  • Diaccurate's estimated revenue per employee is $155,000

Employee Data

  • Diaccurate has 23 Employees.(i)
  • Diaccurate grew their employee count by 10% last year.

Diaccurate's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M81-5%N/AN/A
#2
$19.5M126-2%N/AN/A
#3
$36.3M23422%N/AN/A
#4
$19.7M127-17%N/AN/A
#5
$14.3M920%$179.5MN/A
#6
$49.4M208-8%€201.1MN/A
#7
$44.5M287-3%N/AN/A
#8
$7.6M49N/AN/AN/A
#9
$6.4M41N/AN/AN/A
#10
$17.2M111-15%N/AN/A
Add Company

What Is Diaccurate?

Spin-off from the Pasteur Institute in Paris, DIACCURATE is a late preclinical stage biotechnology company which develops “sole-in-class” therapeutics in oncology and immunotherapy. DIACCURATE is conducting 3 proprietary development programs of highly innovative drug-candidates: the KIF20A inhibitor DIACC2010 disrupts intracellular trafficking to reduce growth of cancer cells while the anti-PLA2G1B antibody DIACC1010 restores CD4 T cells altered functions in cancer and HIV. In the course of 2022, the company will enter its first clinical trial. Led by Dr. Dominique BRIDON, DIACCURATE was cofounded by Prof. Jacques THÈZE, an international leading authority in the field of CD4 biology and Dr Philippe POULETTY, biotech and medtech pioneer, cofounder and CEO of TRUFFLE CAPITAL.

keywords:N/A

N/A

Total Funding

23

Number of Employees

$3.6M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.3M230%N/A
#2
$2.3M23N/AN/A
#3
$2.3M23N/AN/A
#4
$2.3M235%N/A
#5
$4.3M235%N/A